Your browser doesn't support javascript.
loading
Network-based prioritization and validation of regulators of vascular smooth muscle cell proliferation in disease.
Lambert, Jordi; Oc, Sebnem; Worssam, Matthew D; Häußler, Daniel; Solomon, Charles U; Figg, Nichola L; Baxter, Ruby; Imaz, Maria; Taylor, James C K; Foote, Kirsty; Finigan, Alison; Mahbubani, Krishnaa T; Webb, Tom R; Ye, Shu; Bennett, Martin R; Krüger, Achim; Spivakov, Mikhail; Jørgensen, Helle F.
Afiliação
  • Lambert J; Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Oc S; Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Worssam MD; Functional Gene Control Group, MRC Laboratory of Medical Sciences, London, UK.
  • Häußler D; Institute of Clinical Sciences, Faculty of Medicine, Imperial College, London, UK.
  • Solomon CU; Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Figg NL; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Baxter R; TUM School of Medicine and Health, Institute of Experimental Oncology and Therapy Research, Technical University of Munich, Munich, Germany.
  • Imaz M; Department of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, UK.
  • Taylor JCK; Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Foote K; Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Finigan A; Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Mahbubani KT; Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Webb TR; Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Ye S; Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Bennett MR; Collaborative Biorepository for Translational Medicine, Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
  • Krüger A; Department of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, UK.
  • Spivakov M; Department of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, UK.
  • Jørgensen HF; Shantou University Medical College, Shantou, China.
Nat Cardiovasc Res ; 3(6): 714-733, 2024 Jun.
Article em En | MEDLINE | ID: mdl-39215134
ABSTRACT
Aberrant vascular smooth muscle cell (VSMC) homeostasis and proliferation characterize vascular diseases causing heart attack and stroke. Here we elucidate molecular determinants governing VSMC proliferation by reconstructing gene regulatory networks from single-cell transcriptomics and epigenetic profiling. We detect widespread activation of enhancers at disease-relevant loci in proliferation-predisposed VSMCs. We compared gene regulatory network rewiring between injury-responsive and nonresponsive VSMCs, which suggested shared transcription factors but differing target loci between VSMC states. Through in silico perturbation analysis, we identified and prioritized previously unrecognized regulators of proliferation, including RUNX1 and TIMP1. Moreover, we showed that the pioneer transcription factor RUNX1 increased VSMC responsiveness and that TIMP1 feeds back to promote VSMC proliferation through CD74-mediated STAT3 signaling. Both RUNX1 and the TIMP1-CD74 axis were expressed in human VSMCs, showing low levels in normal arteries and increased expression in disease, suggesting clinical relevance and potential as vascular disease targets.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidor Tecidual de Metaloproteinase-1 / Miócitos de Músculo Liso / Proliferação de Células / Fator de Transcrição STAT3 / Redes Reguladoras de Genes / Músculo Liso Vascular Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidor Tecidual de Metaloproteinase-1 / Miócitos de Músculo Liso / Proliferação de Células / Fator de Transcrição STAT3 / Redes Reguladoras de Genes / Músculo Liso Vascular Idioma: En Ano de publicação: 2024 Tipo de documento: Article